Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy

Tero Puolakkainen, Hongqian Ma, Heikki Kainulainen, Arja Pasternack, Timo Rantalainen, Olli Ritvos, Kristiina Heikinheimo, Juha Hulmi, Riku Kiviranta

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Article number20
JournalBMC Musculoskeletal Disorders
Volume18
Number of pages11
ISSN1471-2474
DOIs
Publication statusPublished - 19 Jan 2017
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Bone mu CT
  • Bone-muscle interactions
  • TGF-beta s
  • Animal models
  • Exercise
  • MUSCLE PROTEIN-SYNTHESIS
  • MDX MICE
  • OXIDATIVE CAPACITY
  • MYOSTATIN
  • EXERCISE
  • DENSITY
  • METAANALYSIS
  • DEFICIENCY
  • PREVENTS
  • BLOCKING
  • 3126 Surgery, anesthesiology, intensive care, radiology
  • 3121 Internal medicine

Cite this

Puolakkainen, Tero ; Ma, Hongqian ; Kainulainen, Heikki ; Pasternack, Arja ; Rantalainen, Timo ; Ritvos, Olli ; Heikinheimo, Kristiina ; Hulmi, Juha ; Kiviranta, Riku. / Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy. In: BMC Musculoskeletal Disorders. 2017 ; Vol. 18.
@article{d6b50547f4704e738b0860fc240c88dd,
title = "Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy",
keywords = "Bone mu CT, Bone-muscle interactions, TGF-beta s, Animal models, Exercise, MUSCLE PROTEIN-SYNTHESIS, MDX MICE, OXIDATIVE CAPACITY, MYOSTATIN, EXERCISE, DENSITY, METAANALYSIS, DEFICIENCY, PREVENTS, BLOCKING, 3126 Surgery, anesthesiology, intensive care, radiology, 3121 Internal medicine",
author = "Tero Puolakkainen and Hongqian Ma and Heikki Kainulainen and Arja Pasternack and Timo Rantalainen and Olli Ritvos and Kristiina Heikinheimo and Juha Hulmi and Riku Kiviranta",
year = "2017",
month = "1",
day = "19",
doi = "10.1186/s12891-016-1366-3",
language = "English",
volume = "18",
journal = "BMC Musculoskeletal Disorders",
issn = "1471-2474",
publisher = "BMC",

}

Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy. / Puolakkainen, Tero; Ma, Hongqian; Kainulainen, Heikki; Pasternack, Arja; Rantalainen, Timo; Ritvos, Olli; Heikinheimo, Kristiina; Hulmi, Juha; Kiviranta, Riku.

In: BMC Musculoskeletal Disorders, Vol. 18, 20, 19.01.2017.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy

AU - Puolakkainen, Tero

AU - Ma, Hongqian

AU - Kainulainen, Heikki

AU - Pasternack, Arja

AU - Rantalainen, Timo

AU - Ritvos, Olli

AU - Heikinheimo, Kristiina

AU - Hulmi, Juha

AU - Kiviranta, Riku

PY - 2017/1/19

Y1 - 2017/1/19

KW - Bone mu CT

KW - Bone-muscle interactions

KW - TGF-beta s

KW - Animal models

KW - Exercise

KW - MUSCLE PROTEIN-SYNTHESIS

KW - MDX MICE

KW - OXIDATIVE CAPACITY

KW - MYOSTATIN

KW - EXERCISE

KW - DENSITY

KW - METAANALYSIS

KW - DEFICIENCY

KW - PREVENTS

KW - BLOCKING

KW - 3126 Surgery, anesthesiology, intensive care, radiology

KW - 3121 Internal medicine

U2 - 10.1186/s12891-016-1366-3

DO - 10.1186/s12891-016-1366-3

M3 - Article

VL - 18

JO - BMC Musculoskeletal Disorders

JF - BMC Musculoskeletal Disorders

SN - 1471-2474

M1 - 20

ER -